Abstract: Three-dimensional solar power generation systems are described. The systems are characterized by a plurality of solar panels configured to include pole and equator facing panels and, in various embodiments additional top and/or side panels that form a segmented and dome-shaped assembly. The systems have improved efficiencies particularly with respect to early morning and evening power generation that enable improved power densities on a given land area as compared to traditional solar panel arrays. Methods of deploying the systems are also described.

Abstract: Devices for anchoring one or more solar panels are described. The devices include a container configured to receive ballast material to provide increased mass for anchoring one or more solar panels to a ground surface. The container also includes a solar panel connection system for securing one or more solar panels to the container and may support various additional features providing enhanced stability and protection of other solar array components. The devices may be used in combination with other solar panel support structures to create extended solar panel assemblies which may include additional energy collection features.

Abstract: Three-dimensional solar power generation systems have a plurality of solar panels configured to include pole and equator facing panels and, in various embodiments additional top and/or side panels that form a segmented and dome-shaped assembly. The systems have improved efficiencies particularly with respect to early morning and evening power generation that enable improved power densities on a given land area as compared to traditional solar panel arrays. Methods of deploying the systems are also described.

Abstract: Described herein are methods for lowering glycated hemoglobin (HbA1c) level to treat and/or prevent a diabetes-related disease or disorder by administering to a subject in need thereof, a combination of a sodium-glucose transport protein 2 (SGLT2) inhibitor and a compound of Formula I or a stereoisomer, tautomer, pharmaceutically acceptable salt, or hydrate thereof, wherein the variables of Formula I are as defined herein.

Abstract: Described herein are methods for treating and/or preventing a kidney disease or an associated disorder as measured by an increase in estimated glomerular filtration rate (eGFR) by administering to a subject in need thereof, a combination of a sodium-glucose transport protein 2 (SGLT2) inhibitor and a compound of Formula I or a stereoisomer, tautomer, pharmaceutically acceptable salt, or hydrate thereof, wherein the variables of Formula I are as defined herein.

Abstract: Described herein are methods of for treating and/or preventing Major adverse cardiovascular events (MACE) by administering to a subject in need thereof, a combination of a dipeptidyl peptidase 4 (DPP-4) inhibitor and a compound of Formula I or a stereoisomer, tautomer, pharmaceutically acceptable salt, or hydrate thereof, wherein the variables of Formula I are as defined herein.

Abstract: Three-dimensional solar power generation systems have a plurality of solar panels configured to include pole and equator facing panels and, in various embodiments additional top and/or side panels that form a segmented and dome-shaped assembly. The systems have improved efficiencies particularly with respect to early morning and evening power generation that enable improved power densities on a given land area as compared to traditional solar panel arrays. Methods of deploying the systems are also described.

Abstract: Described herein are methods of for treating and/or preventing Major adverse cardiovascular events (MACE). by administering to a subject in need thereof, a combination of a sodium-glucose transport protein 2 (SGLT2) inhibitor and a compound of Formula I or a stereoisomer, tautomer, pharmaceutically acceptable salt, or hydrate thereof, wherein the variables of Formula I are as defined herein.

Abstract: Three-dimensional solar power generation systems are described. The systems are characterized by a plurality of solar panels configured to include pole and equator facing panels and, in various embodiments additional top and/or side panels that form a segmented and dome-shaped assembly. The systems have improved efficiencies particularly with respect to early morning and evening power generation that enable improved power densities on a given land area as compared to traditional solar panel arrays. Methods of deploying the systems are also described.

Abstract: The invention comprises methods for treating and/or preventing cardiovascular, cholesterol, and lipid related disorders, including atherosclerosis, through co-administration of therapeutically effective amounts of RVX-208 or a pharmaceutically acceptable salt thereof and rosuvastatin or a pharmaceutically acceptable salt thereof. The invention further provides compositions comprising a therapeutically effective amount of RVX-208 or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of rosuvastatin or a pharmaceutically acceptable salt thereof.